Although we confirmed in vitro that the SNHG3/miR-448/DNMT1 molecular axis mediates SEP9 methylation and thus affects the progression of gastric cancer, this study was limited in its ability to further verify this molecular mechanism in vivo. This evidence concerns the gene SNHG3 and gastric cancer.